MELAX EXECUTIVE TEAM

Melax Tech: Natural Language Processing (NLP) technology for pharmaceutical, biomedical, life sciences and healthcare companies.
Andre Pontin
Chief Executive Officer
Andre is an experienced healthcare executive with a proven track record in creating strategic partnerships, scaling startups, large enterprise sales agreements, business development and product innovation. Andre is an integral part of the digital solution landscape and is also an active member in the global digital health ecosystem. He has previously held leadership positions at both 2nd.MD and DoseMe.
Melax Tech: Natural Language Processing (NLP) technology for pharmaceutical, biomedical, life sciences and healthcare companies.
Jingqi Wang
Chief Technology Officer
Jingqi Wang serves as the Chief Technology Officer at Melax Tech, leading the NLP development team. He has ten years of working experience as a software developer before he joined Melax. In the past years, he primarily worked on the development and improvement of clinical Natural Language Processing (NLP) algorithms and applications. He has contributed to multiple top-ranked systems in biomedical NLP competitions.
Melax Tech: Natural Language Processing (NLP) technology for pharmaceutical, biomedical, life sciences and healthcare companies.
Frank Manion, PhD
VP for Innovation
Dr. Manion, VP for Innovation, has held executive positions in biomedical informatics support at two major NCI-designated comprehensive cancer centers. He served as Chief Technology Officer and Deputy CIO at the Fox Chase Cancer Center. Until joining Melax he was the Chief Informatics Officer at the Rogel Cancer Center of the University of Michigan. His research interest are the formal semantic representation of biomedical research and clinical data.
Melax Tech: Natural Language Processing (NLP) technology for pharmaceutical, biomedical, life sciences and healthcare companies.
Hao Ding, PhD
Director of Operations
A biophysicist by training, Dr. Ding was fascinated by natural language processing, machine learning, and the impact of new technology that will bring to the healthcare industry. Since joining Melax Tech in 2018, Hao has been passionate about expanding business development and revenue generation, managing company daily operation, and ultimately contributing to the improvement of the healthcare system. When not working hard in front of his computer, Hao enjoys spending time with his family and sweating in the gym.
Founder
Melax Tech: Natural Language Processing (NLP) technology for pharmaceutical, biomedical, life sciences and healthcare companies.
Hua Xu, PhD
Founder
Dr. Xu is the Founder of Melax Tech. He received his PhD in Biomedical Informatics from Columbia University, and currently is also a part-time professor at The University of Texas Health Science Center at Houston. In the past decade, he has worked on a broad range of challenging NLP topics and clinical NLP methods and systems developed in his lab have been highly recognized. He served as the Chair of AMIA NLP Working Group and currently also leads the NLP Working Group at OHDSI.